Cargando…
In situ Metabolic Profiling of Ovarian Cancer Tumor Xenografts: A Digital Pathology Approach
Metabolic profiling of cancer is a rising interest in the field of biomarker development. One bottleneck of its clinical exploitation, however, is the lack of simple and quantitative techniques that enable to capture the key metabolic traits of tumor from archival samples. In fact, liquid chromatogr...
Autores principales: | Piga, Ilaria, Verza, Martina, Montenegro, Francesca, Nardo, Giorgia, Zulato, Elisabetta, Zanin, Tiziana, Del Bianco, Paola, Esposito, Giovanni, Indraccolo, Stefano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466758/ https://www.ncbi.nlm.nih.gov/pubmed/32974128 http://dx.doi.org/10.3389/fonc.2020.01277 |
Ejemplares similares
-
Metabolic classification of non-small cell lung cancer patient-derived xenografts by a digital pathology approach: A pilot study
por: Ferrarini, Federica, et al.
Publicado: (2023) -
Genetic Perturbation of Pyruvate Dehydrogenase Kinase 1 Modulates Growth, Angiogenesis and Metabolic Pathways in Ovarian Cancer Xenografts
por: Venturoli, Carolina, et al.
Publicado: (2021) -
Implementation of Next Generation Sequencing-Based Liquid Biopsy for Clinical Molecular Diagnostics in Non-Small Cell Lung Cancer (NSCLC) Patients
por: Zulato, Elisabetta, et al.
Publicado: (2021) -
Early assessment of KRAS mutation in cfDNA correlates with risk of progression and death in advanced non-small-cell lung cancer
por: Zulato, Elisabetta, et al.
Publicado: (2020) -
Overcoming platinum-acquired resistance in ovarian cancer
patient-derived xenografts
por: Ricci, Francesca, et al.
Publicado: (2019)